Align Technology (ALGN) Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALGN shares.
View ALGN analyst ratings or view top-rated stocks.

9 Wall Street research analysts have issued twelve-month price objectives for Align Technology's stock. Their ALGN share price forecasts range from $225.00 to $450.00. On average, they anticipate the company's stock price to reach $380.33 in the next twelve months. This suggests a possible upside of 26.9% from the stock's current price.
View analysts price targets for ALGN or view top-rated stocks among Wall Street analysts.

Align Technology's stock was trading at $210.90 at the beginning of the year. Since then, ALGN stock has increased by 42.1% and is now trading at $299.76.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our ALGN earnings forecast.

Align Technology, Inc. (NASDAQ:ALGN) announced its quarterly earnings data on Wednesday, July, 26th. The medical equipment provider reported $1.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.09. The medical equipment provider earned $1 billion during the quarter, compared to the consensus estimate of $985.87 million. Align Technology had a net margin of 8.40% and a trailing twelve-month return on equity of 11.42%.

ETFs with the largest weight of Align Technology (NASDAQ:ALGN) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Guru Favorite Stocks ETF (GFGF), Upholdings Compound Kings ETF (KNGS), BNY Mellon Innovators ETF (BKIV), BlackRock Future Health ETF (BMED), AI Quality Growth ETF (AQGX), First Trust Indxx Medical Devices ETF (MDEV) and Hartford Large Cap Growth ETF (HFGO).

Align Technology updated its FY 2023 earnings guidance on Wednesday, July, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.97 billion-$3.99 billion, compared to the consensus revenue estimate of $3.94 billion.

346 employees have rated Align Technology Chief Executive Officer Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among the company's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), Salesforce (CRM), Mastercard (MA) and Tesla (TSLA).

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALGN stock can currently be purchased for approximately $299.76.

Align Technology (NASDAQ:ALGN) has a market capitalization of $22.94 billion and generates $3.73 billion in revenue each year. The medical equipment provider earns $361.57 million in net income (profit) each year or $4.07 on an earnings per share basis.

The company employs 23,165 workers across the globe.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The official website for the company is www.aligntech.com. The medical equipment provider can be reached via phone at (602) 742-2000, via email at align@ethoscommunication.com, or via fax at 408-470-1010.